Electronic Pill Bottle Monitoring to Promote Medication Adherence for People With Multiple Sclerosis
Completed · Not applicable
Conditions studied: Multiple Sclerosis
In brief
People with multiple sclerosis (MS) have variable adherence to MS medications, making the full efficacy of disease modifying therapies unrealized and the assessment of true treatment failures challenging. Whereas some patients forget to take medications due to active lifestyles, others may have cognitive impairments that prevent them from organizing and planning their regular dosing schedules. An electronic pill cap ("Pillsy") has been developed to record pill taking, timing, and set reminders through a mobile app. Data on adherence can be captured and analyzed remotely for health care provider review.
Key facts
- Study ID
- NCT04130256
- Run by
- Massachusetts General Hospital
- People needed
- 85
- Starts
- 2019-11-15
- Expected to finish
- 2021-01-26
- Last updated by the study team
- 2021-07-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Ability to provide individual written consent
- Ability to understand sufficient levels of English to use the Pillsy app
- Ability to come to Massachusetts General Hospital for two study visits over a 90-day window OR ability to access Zoom for virtual study visits
- Possess a smartphone
- Willingness to follow the study protocol
You may not qualify if…
- Presence of an MS relapse requiring acute management and/or hospitalization
- Daily medication provided by allied health care workers
- Foreign travel preventing electronic remote monitoring
- Expectation of discontinuation of the oral disease modifying therapy (DMT) in the upcoming 90 days for any reason
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.